Medical Devices & Diagnostics Commercialization
Strategic Spinouts accelerates medical devices and diagnostics from early stage innovation to acquisition-ready assets in 12 to 18 months. Our commercialization sprint addresses the specific regulatory, market, and technical hurdles that define this sector while keeping the focus on acquirer alignment and speed to transaction.
The Market Reality for Medical Devices & Diagnostics
This sector operates under strict regulatory oversight and high barriers to entry. Even promising devices can stall without early clarity on intended use, pathway, and market positioning. Acquirers and investors want to see more than technical promise — they need proof the device can be sold, delivered, and supported under commercial conditions. Our model builds this proof into the commercialization process from the outset.
Our Commercialization Sprint Model
Secure Rights
Ensure clean ownership or secure licensing with clear field-of-use definitions and backend economics aligned to commercial goals.
Design the Commercial Model
Define the economic structure — device pricing, consumables, subscription layers — validated through market analysis and early engagements.
Regulatory and Quality Scaffold
Select the appropriate pathway (510(k), De Novo, CLIA, LDT) and implement a lite QMS with risk management sufficient for diligence and pilot programs.
Prove It in Market
Execute acquirer-aligned pilots or early sales to demonstrate clinical and commercial readiness.
Transaction Package
Deliver a complete dataroom containing regulatory, technical, financial, and market proof ready for diligence.
What Makes Our Approach Different
Parallel Execution
Regulatory, commercial, and technical readiness developed simultaneously to compress timelines.
Acquirer-Defined Metrics
We use buyer criteria to shape pilots and market proof.
Lean but Complete
Only what is needed to de-risk and enable a transaction — no unnecessary extensions.
Non-Dilutive Focus
Prioritize funding sources that keep exit options open.
Who We Work With
Device Innovators
Engineers, clinicians, and founders ready to move from prototype to market proof.
Diagnostic Developers
Teams with assay or platform technology that needs market validation and regulatory pathway execution.
Corporate or PE Buyers
Seeking assets that are integration-ready and aligned to strategic plans.
Expected Outcomes
Clean rights secured and documented
Validated commercial model with recurring revenue potential
Regulatory and quality readiness for pilots and diligence
Market proof aligned to acquirer criteria
Complete dataroom ready for transaction
Typical engagement: 12 to 18 months from rights secured to acquisition-ready. Timelines vary by regulatory pathway, market dynamics, and pilot complexity.